Copyright © 2010 Patricia López et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The production of two regulators of the inflammatory response, interleukin 10 (IL-10) and tumor necrosis factor α (TNFα), has been found to be deeply deregulated in SLE patients, suggesting that these cytokines may be involved in the pathogenesis of the disease. Genetic polymorphisms at the promoter regions of IL-10 and TNFα genes have been associated with different constitutive and induced cytokine production. Given that individual steady-state levels of these molecules may deviate an init...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
OBJECTIVE: To assess the role of polymorphisms in the promoter region of the tumor necrosis factor-a...
Objective. To ascertain the possible involvement of functional IL-10 and TNFα cytokine promoter poly...
Systemic lupus erythematosus (SLE) is the prototype autoimmune rheumatic disease. The etiology of th...
Introduction: Glomerulonephritis is a major determinant of the course and prognosis of systemic lupu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with unknown aetiology. According...
<div><p>Background</p><p>A number of observational studies have been conducted to investigate the as...
Introduction: It has been shown that abnormal cytokine profiles in SLE, especially over-production o...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND. Several lines of evidence suggest that...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
<div><p>Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with syst...
Systemic lupus erythematosus (SLE) is characterized by overt polyclonal B-cell activation and autoan...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
OBJECTIVE: To assess the role of polymorphisms in the promoter region of the tumor necrosis factor-a...
Objective. To ascertain the possible involvement of functional IL-10 and TNFα cytokine promoter poly...
Systemic lupus erythematosus (SLE) is the prototype autoimmune rheumatic disease. The etiology of th...
Introduction: Glomerulonephritis is a major determinant of the course and prognosis of systemic lupu...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with unknown aetiology. According...
<div><p>Background</p><p>A number of observational studies have been conducted to investigate the as...
Introduction: It has been shown that abnormal cytokine profiles in SLE, especially over-production o...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND. Several lines of evidence suggest that...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
<div><p>Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with syst...
Systemic lupus erythematosus (SLE) is characterized by overt polyclonal B-cell activation and autoan...
Immunoregulatory cytokine interleukin-10 (IL-10) is elevated in sera from patients with systemic lup...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
OBJECTIVE: To assess the role of polymorphisms in the promoter region of the tumor necrosis factor-a...